A Novel CCR5 Mutation Common in Sooty Mangabeys Reveals SIVsmm Infection of CCR5-Null Natural Hosts and Efficient Alternative Coreceptor Use
In contrast to HIV infection in humans and SIV in macaques, SIV infection of natural hosts including sooty mangabeys (SM) is non-pathogenic despite robust virus replication. We identified a novel SM CCR5 allele containing a two base pair deletion (Δ2) encoding a truncated molecule that is not expressed on the cell surface and does not support SIV entry in vitro. The allele was present at a 26% frequency in a large SM colony, along with 3% for a CCR5Δ24 deletion allele that also abrogates surface expression. Overall, 8% of animals were homozygous for defective CCR5 alleles and 41% were heterozygous. The mutant allele was also present in wild SM in West Africa. CD8+ and CD4+ T cells displayed a gradient of CCR5 expression across genotype groups, which was highly significant for CD8+ cells. Remarkably, the prevalence of natural SIVsmm infection was not significantly different in animals lacking functional CCR5 compared to heterozygous and homozygous wild-type animals. Furthermore, animals lacking functional CCR5 had robust plasma viral loads, which were only modestly lower than wild-type animals. SIVsmm primary isolates infected both homozygous mutant and wild-type PBMC in a CCR5-independent manner in vitro, and Envs from both CCR5-null and wild-type infected animals used CXCR6, GPR15 and GPR1 in addition to CCR5 in transfected cells. These data clearly indicate that SIVsmm relies on CCR5-independent entry pathways in SM that are homozygous for defective CCR5 alleles and, while the extent of alternative coreceptor use in SM with CCR5 wild type alleles is uncertain, strongly suggest that SIVsmm tropism and host cell targeting in vivo is defined by the distribution and use of alternative entry pathways in addition to CCR5. SIVsmm entry through alternative pathways in vivo raises the possibility of novel CCR5-negative target cells that may be more expendable than CCR5+ cells and enable the virus to replicate efficiently without causing disease in the face of extremely restricted CCR5 expression seen in SM and several other natural host species.
Vyšlo v časopise:
A Novel CCR5 Mutation Common in Sooty Mangabeys Reveals SIVsmm Infection of CCR5-Null Natural Hosts and Efficient Alternative Coreceptor Use. PLoS Pathog 6(8): e32767. doi:10.1371/journal.ppat.1001064
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001064
Souhrn
In contrast to HIV infection in humans and SIV in macaques, SIV infection of natural hosts including sooty mangabeys (SM) is non-pathogenic despite robust virus replication. We identified a novel SM CCR5 allele containing a two base pair deletion (Δ2) encoding a truncated molecule that is not expressed on the cell surface and does not support SIV entry in vitro. The allele was present at a 26% frequency in a large SM colony, along with 3% for a CCR5Δ24 deletion allele that also abrogates surface expression. Overall, 8% of animals were homozygous for defective CCR5 alleles and 41% were heterozygous. The mutant allele was also present in wild SM in West Africa. CD8+ and CD4+ T cells displayed a gradient of CCR5 expression across genotype groups, which was highly significant for CD8+ cells. Remarkably, the prevalence of natural SIVsmm infection was not significantly different in animals lacking functional CCR5 compared to heterozygous and homozygous wild-type animals. Furthermore, animals lacking functional CCR5 had robust plasma viral loads, which were only modestly lower than wild-type animals. SIVsmm primary isolates infected both homozygous mutant and wild-type PBMC in a CCR5-independent manner in vitro, and Envs from both CCR5-null and wild-type infected animals used CXCR6, GPR15 and GPR1 in addition to CCR5 in transfected cells. These data clearly indicate that SIVsmm relies on CCR5-independent entry pathways in SM that are homozygous for defective CCR5 alleles and, while the extent of alternative coreceptor use in SM with CCR5 wild type alleles is uncertain, strongly suggest that SIVsmm tropism and host cell targeting in vivo is defined by the distribution and use of alternative entry pathways in addition to CCR5. SIVsmm entry through alternative pathways in vivo raises the possibility of novel CCR5-negative target cells that may be more expendable than CCR5+ cells and enable the virus to replicate efficiently without causing disease in the face of extremely restricted CCR5 expression seen in SM and several other natural host species.
Zdroje
1. GaoF
BailesE
RobertsonDL
ChenY
RodenburgCM
1999 Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397 436 441
2. BailesE
GaoF
Bibollet-RucheF
CourgnaudV
PeetersM
2003 Hybrid origin of SIV in chimpanzees. Science 300 1713
3. PeetersM
JanssensW
FransenK
BrandfulJ
HeyndrickxL
1994 Isolation of simian immunodeficiency viruses from two sooty mangabeys in Cote d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains. AIDS Res Hum Retroviruses 10 1289 1294
4. HirschVM
OlmstedRA
Murphey-CorbM
PurcellRH
JohnsonPR
1989 An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 339 389 392
5. ApetreiC
KaurA
LercheNW
MetzgerM
PandreaI
2005 Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm. J Virol 79 8991 9005
6. SilvestriG
PaiardiniM
PandreaI
LedermanMM
SodoraDL
2007 Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 117 3148 3154
7. SodoraDL
AllanJS
ApetreiC
BrenchleyJM
DouekDC
2009 Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 15 861 865
8. KeeleBF
JonesJH
TerioKA
EstesJD
RudicellRS
2009 Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature 460 515 519
9. Rey-CuilleMA
BerthierJL
Bomsel-DemontoyMC
ChaducY
MontagnierL
1998 Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol 72 3872 3886
10. BroussardSR
StapransSI
WhiteR
WhiteheadEM
FeinbergMB
2001 Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J Virol 75 2262 2275
11. SilvestriG
SodoraDL
KoupRA
PaiardiniM
O'NeilSP
2003 Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18 441 452
12. HolzammerS
HolznagelE
KaulA
KurthR
NorleyS
2001 High virus loads in naturally and experimentally SIVagm-infected African green monkeys. Virology 283 324 331
13. KootM
KeetIPM
RosAHV
de GoedeREY
RoosMTL
1993 Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. AnnInternMed 118 681 688
14. ScarlattiG
TresoldiE
BjorndalA
FredrikssonR
ColognesiC
1997 In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 3 1259 1265
15. BlaakH
van't WoutAB
BrouwerM
HooibrinkB
HovenkampE
2000 In vivo HIV-1 infection of CD45RA+CD4+ T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4+ T cell decline. ProcNatlAcadSciUSA 97 1269 1274
16. Van RijRP
BlaakH
VisserJA
BrouwerM
RientsmaR
2000 Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. JClinInvest 106 1039 1052
17. PandreaI
OnangaR
SouquiereS
Mouinga-OndemeA
BourryO
2008 Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding. J Virol 82 5501 5509
18. PandreaI
ApetreiC
GordonS
BarbercheckJ
DufourJ
2007 Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts. Blood 109 1069 1076
19. RuckerJ
EdingerAL
SharronM
SamsonM
LeeB
1997 Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 71 8999 9007
20. DengHK
UnutmazD
KewalRamaniVN
LittmanDR
1997 Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388 296 300
21. FarzanM
ChoeH
MartinK
MarconL
HofmannW
1997 Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 186 405 411
22. PohlmannS
StolteN
MunchJ
Ten HaaftP
HeeneyJL
1999 Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo. J Infect Dis 180 1494 1502
23. MattapallilJJ
DouekDC
HillB
NishimuraY
MartinM
2005 Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 1093 1097
24. GordonSN
KlattNR
BosingerSE
BrenchleyJM
MilushJM
2007 Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J Immunol 179 3026 3034
25. McCuneJM
2001 The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410 974 979
26. GrossmanZ
Meier-SchellersheimM
PaulWE
PickerLJ
2006 Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 12 289 295
27. OkoyeA
Meier-SchellersheimM
BrenchleyJM
HagenSI
WalkerJM
2007 Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 204 2171 2185
28. LiuZ
CumberlandWG
HultinLE
PrinceHE
DetelsR
1997 Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 16 83 92
29. BosingerSE
LiQ
GordonSN
KlattNR
DuanL
2009 Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 119 3556 3572
30. JacquelinB
MayauV
TargatB
LiovatAS
KunkelD
2009 Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 119 3544 3555
31. BrenchleyJM
PriceDA
SchackerTW
AsherTE
SilvestriG
2006 Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12 1365 1371
32. BrenchleyJM
SchackerTW
RuffLE
PriceDA
TaylorJH
2004 CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200 749 759
33. PandreaIV
GautamR
RibeiroRM
BrenchleyJM
ButlerIF
2007 Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J Immunol 179 3035 3046
34. VeazeyRS
DeMariaM
ChalifouxLV
ShvetzDE
PauleyDR
1998 Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280 427 431
35. FavreD
LedererS
KanwarB
MaZM
ProllS
2009 Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 5 e1000295
36. RaffatelluM
SantosRL
VerhoevenDE
GeorgeMD
WilsonRP
2008 Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14 421 428
37. CecchinatoV
TrindadeCJ
LaurenceA
HeraudJM
BrenchleyJM
2008 Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol 1 279 288
38. BrenchleyJM
PaiardiniM
KnoxKS
AsherAI
CervasiB
2008 Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112 2826 2835
39. LiuR
PaxtonWA
ChoeS
CeradiniD
MartinSR
1996 Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 367 377
40. SamsonM
LibertF
DoranzBJ
RuckerJ
LiesnardC
1996 Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 722 725
41. HuangY
PaxtonW
WolinskySM
NeumannAU
ZhangL
1996 The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 2 1240 1243
42. DeanM
CarringtonM
WinklerC
HuttleyGA
SmithMW
1996 Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 273 1856 1862
43. ChenZ
KwonD
JinZ
MonardS
TelferP
1998 Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J Exp Med 188 2057 2065
44. PalaciosE
DigilioL
McClureHM
ChenZ
MarxPA
1998 Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus. Curr Biol 8 943 946
45. SantiagoML
RangeF
KeeleBF
LiY
BailesE
2005 Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Tai Forest, Cote d'Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2. J Virol 79 12515 12527
46. ApetreiC
GautamR
SumpterB
CarterAC
GaufinT
2007 Virus subtype-specific features of natural simian immunodeficiency virus SIVsmm infection in sooty mangabeys. J Virol 81 7913 7923
47. MilushJM
ReevesJD
GordonSN
ZhouD
MuthukumarA
2007 Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host. J Immunol 179 3047 3056
48. SaitaY
KondoM
ShimizuY
2007 Species selectivity of small-molecular antagonists for the CCR5 chemokine receptor. Int Immunopharmacol 7 1528 1534
49. KetasTJ
KuhmannSE
PalmerA
ZuritaJ
HeW
2007 Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands. Virology 364 281 290
50. AlkhatibG
LiaoF
BergerEA
FarberJM
PedenKW
1997 A new SIV co-receptor, STRL33. Nature 388 238
51. ForteS
HarmonME
PinedaMJ
OverbaughJ
2003 Early- and intermediate-stage variants of simian immunodeficiency virus replicate efficiently in cells lacking CCR5. J Virol 77 9723 9727
52. LaurenA
VodrosD
ThorstenssonR
FenyoEM
2006 Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): evolution of coreceptor use varies with pathogenic outcome. J Gen Virol 87 581 594
53. ChenZ
ZhouP
HoDD
LandauNR
MarxPA
1997 Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 71 2705 2714
54. ZhangY
LouB
LalRB
GettieA
MarxPA
2000 Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J Virol 74 6893 6910
55. ChenZ
GettieA
HoDD
MarxPA
1998 Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Virology 246 113 124
56. OwenSM
MasciotraS
NovembreF
YeeJ
SwitzerWM
2000 Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells. J Virol 74 5702 5708
57. WolinskySM
VeazeyRS
KunstmanKJ
KlassePJ
DufourJ
2004 Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses. Virology 328 19 29
58. VeazeyRS
KlassePJ
KetasTJ
ReevesJD
PiatakMJr
2003 Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. J Exp Med 198 1551 1562
59. UnutmazD
XiangW
SunshineMJ
CampbellJ
ButcherE
2000 The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J Immunol 165 3284 3292
60. SharronM
PohlmannS
PriceK
LolisE
TsangM
2000 Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood 96 41 49
61. ElbimC
MonceauxV
MuellerYM
LewisMG
FrancoisS
2008 Early divergence in neutrophil apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J Immunol 181 8613 8623
62. LiQ
EstesJD
DuanL
JessurunJ
PambuccianS
2008 Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J Infect Dis 197 420 429
63. PickerLJ
HagenSI
LumR
Reed-InderbitzinEF
DalyLM
2004 Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J Exp Med 200 1299 1314
64. GiorgiJV
HultinLE
McKeatingJA
JohnsonTD
OwensB
1999 Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179 859 870
65. EstesJD
GordonSN
ZengM
ChahroudiAM
DunhamRM
2008 Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques. J Immunol 180 6798 6807
66. LedererS
FavreD
WaltersKA
ProllS
KanwarB
2009 Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLoS Pathog 5 e1000296
67. BernsteinI
1971 The influence of introductory techniques on the formation of captive mangabey groups. Primates 12 33 44
68. Georges-CourbotMC
LuCY
MakuwaM
TelferP
OnangaR
1998 Natural infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus. J Virol 72 600 608
69. HummelS
SchmidtD
KremeyerB
HerrmannB
OppermannM
2005 Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons. Genes Immun 6 371 374
70. HedrickPW
VerrelliBC
2006 “Ground truth” for selection on CCR5-Delta32. Trends Genet 22 293 296
71. ConnorRI
ChenBK
ChoeS
LandauNR
1995 Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206 935 944
72. RongR
LiB
LynchRM
HaalandRE
MurphyMK
2009 Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog 5 e1000594
73. BurioniR
PlaisantP
RiccioML
RossoliniGM
SantangeloR
1995 Engineering human monoclonal antibody fragments: a recombinant enzyme-linked Fab. New Microbiol 18 127 133
74. GautamR
CarterAC
KatzN
ButlerIF
BarnesM
2007 In vitro characterization of primary SIVsmm isolates belonging to different lineages. In vitro growth on rhesus macaque cells is not predictive for in vivo replication in rhesus macaques. Virology 362 257 270
75. TaaffeJ
ChahroudiA
EngramJ
SumpterB
MeekerT
A five-year longitudinal analysis of naturally SIV-infected sooty mangabeys reveals a slow but progressive CD4+ T-cell decline whose magnitude is not predicted by viral load or immune activation. J Virol
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 8
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Contribution of Coagulases towards Disease and Protective Immunity
- Early Severe Inflammatory Responses to Uropathogenic Predispose to Chronic and Recurrent Urinary Tract Infection
- Immune Modulation with Sulfasalazine Attenuates Immunopathogenesis but Enhances Macrophage-Mediated Fungal Clearance during Pneumonia
- Dissecting the Genetic Architecture of Host–Pathogen Specificity